Literature DB >> 15064462

A bacterial two-hybrid system based on transcription activation.

Simon L Dove1, Ann Hochschild.   

Abstract

We describe the use of a bacterial two-hybrid system for the study of protein-protein interactions in Escherichia coli. This system is based on transcription activation and involves the synthesis of two fusion proteins within the bacterial cell whose interaction stimulates transcription of a reporter gene. Specifically, one of the fusion proteins can function as a transcription activator when its interaction partner is fused to a subunit of the bacterial RNA polymerase. This bacterial two-hybrid system has been used to study a number of interacting proteins from both prokaryotes and eukaryotes, and can be used to find interacting proteins from complex protein libraries.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15064462     DOI: 10.1385/1-59259-762-9:231

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  62 in total

Review 1.  Diversity in genetic in vivo methods for protein-protein interaction studies: from the yeast two-hybrid system to the mammalian split-luciferase system.

Authors:  Bram Stynen; Hélène Tournu; Jan Tavernier; Patrick Van Dijck
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  Human polyhomeotic homolog 3 (PHC3) sterile alpha motif (SAM) linker allows open-ended polymerization of PHC3 SAM.

Authors:  Angela K Robinson; Belinda Z Leal; David R Nanyes; Yogeet Kaur; Udayar Ilangovan; Virgil Schirf; Andrew P Hinck; Borries Demeler; Chongwoo A Kim
Journal:  Biochemistry       Date:  2012-06-28       Impact factor: 3.162

3.  The interaction between sigma70 and the beta-flap of Escherichia coli RNA polymerase inhibits extension of nascent RNA during early elongation.

Authors:  Bryce E Nickels; Sean J Garrity; Vladimir Mekler; Leonid Minakhin; Konstantin Severinov; Richard H Ebright; Ann Hochschild
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-10       Impact factor: 11.205

4.  ExsE, a secreted regulator of type III secretion genes in Pseudomonas aeruginosa.

Authors:  Arne Rietsch; Isabelle Vallet-Gely; Simon L Dove; John J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-23       Impact factor: 11.205

5.  RNA-mediated destabilization of the sigma(70) region 4/beta flap interaction facilitates engagement of RNA polymerase by the Q antiterminator.

Authors:  Bryce E Nickels; Christine W Roberts; Jeffrey W Roberts; Ann Hochschild
Journal:  Mol Cell       Date:  2006-11-03       Impact factor: 17.970

6.  A sigma-core interaction of the RNA polymerase holoenzyme that enhances promoter escape.

Authors:  Mark Leibman; Ann Hochschild
Journal:  EMBO J       Date:  2007-03-01       Impact factor: 11.598

7.  Ribosomal Synthesis of Macrocyclic Peptides in Vitro and in Vivo Mediated by Genetically Encoded Aminothiol Unnatural Amino Acids.

Authors:  John R Frost; Nicholas T Jacob; Louis J Papa; Andrew E Owens; Rudi Fasan
Journal:  ACS Chem Biol       Date:  2015-05-15       Impact factor: 5.100

8.  A two-subunit bacterial sigma-factor activates transcription in Bacillus subtilis.

Authors:  Shawn R MacLellan; Veronica Guariglia-Oropeza; Ahmed Gaballa; John D Helmann
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-25       Impact factor: 11.205

9.  Interaction of CarD with RNA polymerase mediates Mycobacterium tuberculosis viability, rifampin resistance, and pathogenesis.

Authors:  Leslie A Weiss; Phillip G Harrison; Bryce E Nickels; Michael S Glickman; Elizabeth A Campbell; Seth A Darst; Christina L Stallings
Journal:  J Bacteriol       Date:  2012-08-17       Impact factor: 3.490

10.  Structure of the polycomb group protein PCGF1 in complex with BCOR reveals basis for binding selectivity of PCGF homologs.

Authors:  Sarah E Junco; Renjing Wang; John C Gaipa; Alexander B Taylor; Virgil Schirf; Micah D Gearhart; Vivian J Bardwell; Borries Demeler; P John Hart; Chongwoo A Kim
Journal:  Structure       Date:  2013-03-21       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.